The question behind the question is usually: "How much longer will I be able to get compounded semaglutide at this price?" The pattern we see: patients conflate three separate timelines: Patent expiration (2031-2033 for the formulations that matter) FDA shortage list removal (expected late 2026 to Q1 2027) Generic market entry (2027 for oral, 2031-2032 for injectable, assuming no patent challenges) The timeline that affects current compounded access is number 2, not number 1
This can help you identify patterns and adjust your approach accordingly
In general, prices of the 3-milligram (mg), 7-mg, and 14-mg Rybelsus tablets are likely to be very close or the same
Diabetes and low glucose tolerance
For someone with UC, even mild fluid losses can worsen fatigue, dizziness, and kidney strain, and significant vomiting or diarrhea can also mask or aggravate a flare, so we watch hydration and electrolytes closely. This is why working with a registered dietitian who specializes in IBD can help, Gaffen says